Arch Therapeutics, Inc.
ARTH
$0.20
$0.042627.07%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.65M | -1.47M | -2.68M | -2.46M | -1.82M |
| Total Depreciation and Amortization | 400.00 | 600.00 | 700.00 | 700.00 | 300.00 |
| Total Amortization of Deferred Charges | 415.00K | 422.00K | 1.02M | 830.70K | 634.00K |
| Total Other Non-Cash Items | 3.97M | 0.00 | 25.90K | 35.70K | 41.30K |
| Change in Net Operating Assets | 356.10K | 346.40K | 776.90K | 363.30K | 250.10K |
| Cash from Operations | -911.60K | -700.20K | -862.60K | -1.23M | -897.50K |
| Capital Expenditure | -- | -- | -- | -4.50K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -4.50K | -- |
| Total Debt Issued | 950.00K | 625.00K | 950.00K | -740.00K | 990.00K |
| Total Debt Repaid | -34.80K | -104.30K | -104.30K | -102.40K | -35.40K |
| Issuance of Common Stock | -- | -- | -- | 2.21M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 915.20K | 520.70K | 845.70K | 1.37M | 954.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.60K | -179.40K | -16.90K | 136.20K | 57.00K |